Abnormal Lipid Metabolism and Renal Disorders

Tohoku Journal of Experimental Medicine

Volumn 181, Issue 3, 1997, Pages 321-337

  Saito, Takao ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetic nephropathy; Focal glomerular sclerosis; Hyperlipidemia; Lipoprotein glomerulopathy; Type III hyperlipoproteinemia

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; LIPID;

ANIMAL; DIABETIC NEPHROPATHY; DISEASE MODEL; FABRY DISEASE; FOCAL GLOMERULOSCLEROSIS; GENETICS; GLYCOGEN STORAGE DISEASE TYPE 1; HUMAN; HYPERLIPIDEMIA; HYPERLIPOPROTEINEMIA TYPE 3; KIDNEY DISEASE; LIPID METABOLISM; METABOLISM; REVIEW;

ANIMALS; APOLIPOPROTEIN E2; APOLIPOPROTEINS E; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; FABRY DISEASE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GLYCOGEN STORAGE DISEASE TYPE I; HUMANS; HYPERLIPIDEMIAS; HYPERLIPOPROTEINEMIA TYPE III; KIDNEY DISEASES; LIPID METABOLISM; LIPIDS;

EID: 0031086560     PISSN: 00408727     EISSN: None     Source Type: Journal    
DOI: 10.1620/tjem.181.321     Document Type: Review

References (56)

1. Amatruda, J.M., Margolis, S. & Hutchins, G.M. (1974) Type III hyperlipoproteinemia with mesangial foam cells in renal glomeruli. Arch. Pathol., 98, 51-54.
2. Amenomori, M., Haneda, M., Morikawa, J., Nishigaki, I., Maeda, S., Hidaka, H., Kikkawa, R. & Shigeta, Y. (1994) A case of lipoprotein glomerulopathy successfully treated with probucol. Nephron, 67, 109-113.
3. Baker, L., Dahlem, S., Goldfarb, S., Kern, E.F.O., Stanley, C.A., Egler, J., Olshan, J.S. & Heyman, S. (1989) Hyperfiltration and renal disease in glycogen storage disease, type I. Kidney Int., 35, 1345-1350.
4. Brown, M.S. & Goldstein, J.L. (1983) Lipoprotein metabolism in the macrophage: Implication for cholesterol deposition in atherosclerosis. Ann. Rev. Biochem., 52, 223-261.
5. Coritsidis, G., Rifici, V., Gupta, S., Rie., J., Shan, Z., Neugarten, J. & Schlondorff, D. (1991) Preferential binding of oxidized LDL to rat glomeruli in vivo and cultured mesangial cells in vitro. Kidney Int., 39, 858-866.
6. Chen, Y.T., Coleman, R.A., Scheinman, J.I., Kolbeck, P.C. & Sidbury, J.B. (1988) Renal disease in type I glycogen storage disease. N. Engl. J. Med., 318, 7-11.
7. Churg, J., Habib, R. & White, R.H.R. (1970) Pathology of the nephrotic syndrome in children: A report for the International Study of Kidney Disease in Children. Lancet, i, 1299-1302.
8. Churg, J., Bernstein, J. & Glassock, R.J. (1995) Renal Disease: Classification and Atlas of Glomerular Diseases, 2nd ed., Igaku-Shoin, New York, Tokyo, pp. 450-475.
9. Diamond, J.R. & Karnovsky, M.J. (1987) Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol supplementation. Kidney Int., 32, 671-678.
10. Djamali, A., Cristol, J.P., Turc-Baron, C., Baron, C., Beucler, I., Baldet, P. & Mourad, G. (1996) Glomérulopathie lipoprotéinique: Un nouveau cas français avec récidive sur le transplant. Presse. Med., 25, 798-802.
11. Ellis, D., Orchard, T.J., Lombardozzi, S., Yunis, E.J., McCauley, J., Agostini, R. & Diamond, J.R. (1995) Atypical hyperlipidemia and nephropathy associated with apolipoprotein E homozygosity. J. Am. Soc. Nephrol., 6, 1170-1177.
12. Elshourbagy, N.A., Liao, W.S., Mahley, R.W. & Taylor, J.M. (1985) Apolipoprotein E mRNA is abundant in the brain and adrenal, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc. Natl. Acad. Sci. USA, 82, 203-207.
13. Faraggiana, T. & Churg, J. (1987) Renal lipidoses: A review. Hum. Pathol., 18, 661-679.
14. Fredrickson, D.S., Morganroth, J. & Levy, R.I., (1975) Type III hyperlipoproteinemia: An analysis of two contemporary definitions. Ann. Intern. Med., 82, 150-157.
15. French, S.W., Yamanaka, W. & Ostwald, R. (1967) Dietary induced glomerulosclerosis in the guinea pig. Arch. Pathol., 83, 204-210.
16. Furuta, T., Saito, T., Ootaka, T., Soma, J., Obara, K., Abe, K. & Yoshinaga, K. (1993) The role of macrophages in diabetic glomerulosclerosis. Am. J. Kidney Dis., 21, 480-485.
17. Gjone, E. (1981) Familial lecithin: Cholesterol acyltransferase deficiency - A new metabolic disease with renal involvement. Adv. Nephrol., 10, 167-185.
18. Grond, J., Weening, J.J. & Elema, J.D. (1984) Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside. Lab. Invest., 51, 277-285.
19. Habib, R. (1973) Focal glomerulosclerosis. Kidney Int., 4, 355-361.
20. Harris, K.P.G., Purkerson, M.L., Yates, J. & Klahr, S. (1990) Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome. Am. J. Kidney Dis., 15, 16-23.
21. Hazzard, W.R., Porte, D., Jr. & Bierman, E.L. (1972) Abnormal lipid composition of very low density lipoproteins in diagnosis of broad-beta disease (Type III hyperlipoproteinemia). Metabolism, 21, 1009-1019.
22. Howard, B.V. (1987) Lipoprotein metabolism in diabetes mellitus. J. Lipid Res., 28, 613-628.
23. Imai, Y., Matsumura, H., Miyajima, H. & Oka, K. (1977) Serum and tissue lipids and glomerulonephritis in the spontaneously hypercholesterolemic rat, with a note on the effects of gonadectomy. Atherosclerosis, 27, 165-178.
24. Jeannet, F.A., Denton, R.M. & Jeanrenaud, B. (1981) Stimulation of hepatic lipogenesis and acetyl-coenzyme A carboxylase by vasopressin. Biochem. J., 198, 485-490.
25. Keane, W.F., Kasiske, B.L. & O'Donnell, M.P. (1988) Lipids and progressive glomerulosclerosis. Am. J. Nephrol., 8, 261-271.
26. Kees-Folts, D. & Diamond, J.R. (1993) Relationship between hyperlipidemia, lipid mediators, and progressive glomerulosclerosis. Am. J. Nephrol., 13, 365-375.
27. Koitabashi, Y., Ikoma, M., Miyahara, T., Fujita, R., Mio, H., Ishida, M., Shimizu, K. & Sakaguchi, H. (1990) Long-term follow-up of a paediatric case of lipoprotein glomerulopathy. Pediatr. Nephrol., 4, 122-128.
28. Kurihara, I., Saito, T., Obara, K., Shoji, Y., Hirai, M., Soma, J., Sato, H., Imai, Y. & Abe, K. (1996) Effect of a non peptide vasopressin V1 antagonist (OPC-21268) on experimental accelerated focal glomerulosclerosis. Nephron, 73, 629-636.
29. Mahley, R.W. (1988) Apolipoprotein: Cholesterol transport protein with expanding role in cell biology. Science, 240, 622-630.
30. Matsubara, M., Taguma, Y., Saito, T., Yoshinaga, K., Furuyama, T. & Sakaguchi, H. (1990) Clinico-pathological features in four patients with Fabry's disease: The possible role of degenerative lesions in the interstitial vessels for renal dysfunction. Jpn. J. Nephrol., 32, 237-243. (abstract in English)
31. Meyrier, A., Dairou, F., Callard, P. & Mougenot, B. (1995) Lipoprotein glomerulopathy: First case in a white European. Nephrol. Dial. Transplant., 10, 546-549.
32. Moorhead, J.F., El-Nahas, M., Chan, M.K. & Varghese, Z. (1982) Lipid nephrotoxicity in chronic progressive glomerular and tubulointerstitial disease. Lancet, 2, 1309-1311.
33. Obara, K., Saito, T., Shoji, Y., Chiba, J., Soma, T., Sato, H. & Yoshinaga, K. (1992) Administration of triton WR 1339 aggravates chronic aminonucleoside nephrosis. Nephron, 60, 119-120.
34. Obara, K., Saito, T., Sato, H., Ogawa, M., Igarashi, Y. & Yoshinaga, K. (1993) Renal histology in two adult patients with type I glycogen storage disease. Clin. Nephrol., 39, 59-64.
35. Oikawa, S., Suzuki, N., Sakuma, E., Saito, T., Namai, K., Kotake, H., Fujii, Y. & Toyota, T. (1991) Abnormal lipoprotein and apolipoprotein pattern in lipoprotein glomerulopathy. Am. J. Kidney Dis., 18, 553-558.
36. Oikawa, S., Matsunaga, A., Saito, T., Sato, H., Seki, T., Hoshi, K., Hayasaka, K., Kotake, H., Midorikawa, H., Sekikawa, A., Hara, S., Abe, K., Toyota, T., Jingami, H., Nakamura, H. & Sasaki, J. (1997) Apolipoprotein E Sendai (Arginine 145→ Proline): A new variant associated with lipoprotein glomerulopathy. J. Am. Soc. Nephrol., 8. (in press)
37. Reaven, G.M. (1987) Non-insulin-dependent diabetes mellitus, abnormal lipoprotein metabolism, and atherosclerosis. Metabolism, 36, Suppl. 1, 1-8.
38. Rich, A.R. (1957) A hitherto undescribed valnerability of the juxtamedullary glomeruli in lipoid nephrosis. Bull. Johns Hopkins Hosp., 100, 173-186.
39. Rossi, R. & Scharrer, E. (1993) Mechanisms of the effects of vasopressin plasma levels of free fatty acids and triglyceride in pygmy goats. Comp. Biochem. Physiol. [A], 104, 287-290.
40. Saito, T. & Atkins, R.C. (1990) Contribution of mononuclear leucocytes to the progression of experimental focal glomerular sclerosis. Kidney Int., 37, 1076-1083.
41. Saito, T., Sato, H., Akiu, N., Ootaka, T., Furuyama, T. & Yoshinaga, K. (1987a) Focal glomerular sclerosis in non-nephrotic patients with hyperlipidemia. Jpn. J. Nephrol., 29, 1107-1114.
42. Saito, T., Sumithran, E., Glasgow, E.F. & Atkins, R.C. (1987b) The enhancement of aminonucleoside nephrosis by the co-administration of protamine. Kidney Int., 32, 691-699.
43. Saito, T., Sato, H., Kudo, K., Oikawa, S., Shibata, T., Hara, Y., Yoshinaga, K. & Sakaguchi H. (1989) Lipoprotein glomerulopathy: Glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia. Am. J. Kidney Dis., 13, 148-153.
44. Saito, T., Sato, H., Obara, K., Yamakage, K., Abe, K., Furuyama, T. & Yoshinaga, K. (1990) Progression of experimental focal glomerulosclerosis in the spontaneously hypertensive rats. J. Lab. Clin. Med., 115, 165-173.
45. Saito, T., Sato, H., Oikawa, S., Kudo, S., Kurihara, I., Nakayama, K., Abe, K., Yoshinaga, K. & Sakaguchi, H. (1993a) Lipoprotein glomerulopathy: Report of a normolipidemic case and review of the literature. Am. J. Nephrol., 13, 64-68.
46. Saito, T., Ootaka, T., Sato, H., Furuta, T., Sato, T., Soma, J., Abe, K. & Yoshinaga, K. (1993b) Participation of macrophages in segmental endocapillary proliferation preceding focal glomerular sclerosis. J. Pathol., 170, 179-185.
47. Saito, T., Sato, H. & Oikawa, S. (1995) Lipoprotein glomerulopathy - A new aspect of lipid induced glomerular injury -. Nephrology, 1, 17-24.
48. Saito, T., Oikawa, S., Sato, H. & Chiba, J. (1997) Lipoprotein glomerulopathy and its pathogenesis. Contrib. Nephrol., 120, 30-38.
49. Schlondorff, D. (1993) Cellular mechanisms of lipid injury in the glomerulus. Am. J. Kidney Dis., 22, 72-82.
50. Suzaki, K., Kobori, S., Ueno, S., Uehara, M., Kayashima, T., Takeda, H., Fukuda, S., Takahashi, K., Nakamura, N., Uzawa, H. & Shichiri, M. (1990) Effect of plasmapheresis on familial type III hyperlipoproteinemia associated with glomerular lipidosis, nephrotic syndrome and diabetes mellitus. Atherosclerosis, 80, 181-189.
51. Takemura, T., Yoshioka, K., Aya, N., Murakami, K., Matsumoto, A., Itakura, H., Kodama, T., Suzuki, H. & Maki, S. (1993) Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases. Kidney Int., 43, 918-927.
52. van Goor, H., Filder, V., Weening, J.J. & Grond, J. (1991) Determinants of focal and segmental glomerulosclerosis in the rat after renal ablation. Evidence for involvement of macrophages and lipids. Lab. Invest., 64, 754-765.
53. von Gierke, E. (1929) Hepato-Nephromegalia glykogenica. (Glykogenspeicherkrankheit der Leber und Nieren.) Beitr. Pathol. Anat., 82, 497-513.
54. Watanabe, Y., Itoh, Y., Yoshida, F., Fukatsu, A., Itoh, Y., Matsuo, S. & Sakamoto, N. (1989) A case of nephrotic syndrome with glomerular lipoprotein deposition with capillary ballooning and mesangiolysis. Nephron, 51, 265-270.
55. Yoshikawa, N. & Yamasaki, K. (1991) Renal lesions of hyperlipidemic Imai rats: A spontaneous animal model of focal glomerulosclerosis. Nephron, 59, 471-476.
56. Zhang, P., Matalon, R., Kaplan, L., Kumar, A. & Gallo, G. (1994) Lipoprotein glomerulopathy: First report in a Chinese male. Am. J. Kiney Dis., 24, 942-950.